Study: Statins Don’t Increase Cancer

Statin drugs that lower LDL cholesterol are safe long term, an 11-year study concludes. The study found that the drugs lowered the risk of heart attack and strokes 23%. And they didn’t increase the risk of cancer or other diseases. More than 20,000 people were part of the study. All had an above average risk of heart disease and other blood vessel problems. They were randomly assigned to take either simvastatin (Zocor) or placebo (fake) pills. The original study lasted 5 years. After that, people who got the placebo at first could take the statin if a doctor prescribed it. Researchers kept track of people for another 6 years. They found no difference between the two groups in their rates of cancer or deaths from non-heart diseases. The journal Lancet published the study online. HealthDay News wrote about it November 22.

Content restricted. Requires subscription

Home BP Tracking May Predict Brain Risk

A form of home blood pressure monitoring may show which older adults are most at risk for a form of dementia, a new study suggests. The study included 72 people. Their average age was 82. Doctors gave them 2 tests. Each person wore a monitor for 24 hours. It measured their blood pressure at regular intervals, day and night. People also got magnetic resonance imaging (MRI) scans of the brain. They got the same tests again 2 years later. In the MRI, researchers looked for white spots known as white matter hyperintensities. These spots are signs of damage to small blood vessels. They have been linked with a reduction in memory and thinking skills. Some people’s home-measured blood pressure got worse during the 2-year study. They tended to have more white spots in the brain than people with lower blood pressure. They also did worse on tests of mental function.

Content restricted. Requires subscription